Privia Health Group (PRVA) closed at $24.69 on November 19, 2026, up 0.4% from the previous close, on volume of 1,664,361 shares (30-day average 1,310,899).
Data as of November 19, 2026.
19-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 18, 2026 | Calendar Call Spread | 20-Nov : 18-Dec-26 25 C | 404 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days
Privia Health: Stronger ACO Savings and Raised 2026 Outlook Support $30 Price Target
TipRanks (Thu, 19-Nov 8:06 AM ET)
TipRanks (Thu, 19-Nov 8:01 AM ET)
TipRanks (Thu, 19-Nov 3:01 AM ET)
Evercore ISI Reaffirms Their Buy Rating on Privia Health Group (PRVA)
TipRanks (Wed, 18-Nov 9:35 AM ET)
Privia Health Reports Record MSSP Shared Savings Growth
TipRanks (Wed, 18-Nov 8:54 AM ET)
Globe Newswire (Wed, 18-Nov 8:30 AM ET)
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
Globe Newswire (Thu, 5-Nov 6:00 AM ET)
Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
Globe Newswire (Mon, 2-Nov 8:30 AM ET)
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
Globe Newswire (Thu, 8-Oct 9:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of November 19, 2026, PRVA stock price climbed to $24.69 with 1,664,361 million shares trading.
PRVA has a beta of 0.10, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.00 to the broad based SPY ETF.
PRVA has a market cap of $3.15 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $657 million in Revenue and $.21 earnings per share. This beat revenue expectation by $49 million and met earnings estimates .
In the last 3 years, PRVA traded as high as $28.82 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, IWM, VTI, VB, VBK.
PRVA has outperformed the market in the last year with a price return of +9.6% while the SPY ETF gained +9.2%. PRVA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.9% and +3.1%, respectively, while the SPY returned -6.7% and -2.3%, respectively.
PRVA support price is $24.01 and resistance is $25.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.